These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 36845153

  • 1. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects.
    Couvidou A, Rojas-Jiménez G, Dupuis A, Maître B.
    Front Immunol; 2023; 14():1125367. PubMed ID: 36845153
    [Abstract] [Full Text] [Related]

  • 2. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S.
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [Abstract] [Full Text] [Related]

  • 3. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
    Panch SR, Guo L, Vassallo R.
    Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
    [Abstract] [Full Text] [Related]

  • 4. Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets.
    Heuer L, Blumenberg D.
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):287-90. PubMed ID: 15870549
    [Abstract] [Full Text] [Related]

  • 5. Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion.
    Peña JR, Saidman SL, Girouard TC, Meister E, Dzik WH, Makar RS.
    Am J Hematol; 2014 Sep; 89(9):E133-7. PubMed ID: 24816643
    [Abstract] [Full Text] [Related]

  • 6. Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics.
    Chen X, Zhao Y, Lv Y, Xie J.
    Platelets; 2024 Dec; 35(1):2306983. PubMed ID: 38314765
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention and management of platelet transfusion refractoriness.
    Novotny VM.
    Vox Sang; 1999 Dec; 76(1):1-13. PubMed ID: 9933848
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
    Fagundes IS, Franz JM, Jobim MS, Arend A, Merzoni J, Cardone JM, Gil B, Sekine L, Jobim LF.
    Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
    [Abstract] [Full Text] [Related]

  • 11. Platelet transfusions: the problem of refractoriness.
    Murphy MF, Waters AH.
    Blood Rev; 1990 Mar; 4(1):16-24. PubMed ID: 2182145
    [Abstract] [Full Text] [Related]

  • 12. Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice.
    Couvidou A, Angénieux C, Ruch L, Mangin PH, Gachet C, Maître B.
    Blood Adv; 2023 Apr 25; 7(8):1356-1365. PubMed ID: 36490266
    [Abstract] [Full Text] [Related]

  • 13. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
    Xia WJ, Ye X, Tian LW, Xu XZ, Chen YK, Luo GP, Bei CH, Deng J, Santoso S, Fu YS.
    Transfus Med; 2010 Aug 01; 20(4):269-74. PubMed ID: 20136782
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov 01; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

  • 17. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J, Lim YM, Park KD, Han BY, Kim YH, Han KS, Park MH.
    Korean J Lab Med; 2009 Oct 01; 29(5):481-9. PubMed ID: 19893359
    [Abstract] [Full Text] [Related]

  • 18. A mini-review on platelet refractoriness.
    Rebulla P.
    Haematologica; 2005 Feb 01; 90(2):247-53. PubMed ID: 15710579
    [Abstract] [Full Text] [Related]

  • 19. ABSOLUTE PLATELET REFRACTORINESS ASSOCIATED WITH HLA ANTIBODIES: A CASE REPORT.
    Vora M, Ong M, Al-Delfi F, Dela Cruz N, Veillon D, Cotelingam J.
    J La State Med Soc; 2016 Feb 01; 168(1):8-11. PubMed ID: 26986860
    [Abstract] [Full Text] [Related]

  • 20. Strategies for managing refractoriness to platelet transfusions.
    Dan ME, Schiffer CA.
    Curr Hematol Rep; 2003 Mar 01; 2(2):158-64. PubMed ID: 12901147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.